KSB represents Glenmark Pharmaceuticals in acquisition of Medicamenta
Glenmark Pharmaceuticals Ltd. is the Indian leader in the development of newmolecules in mainly inflammation and metabolic disorders. The company operatesin more than eighty countries worldwide and the acquisition of Medicamenta a.s.represents a strategic entry into two of the fastest growing markets in the EU.
Other articles
KŠB Ranked in Legal 500 2026
Following our success in last week’s Chambers Europe Guide, we are pleased to confirm our position among the leading law firms in the Czech Republic also in the Legal 500 2026 rankings published by Legal 500.
KŠB once again ranked among leading law firms in Chambers Europe 2026
KŠB has once again been recognised in the prestigious Chambers Europe Guide 2026, confirming its strong position across a broad range of practice areas. The firm achieved rankings in multiple categories, including top-tier placements and numerous individual recognitions.
KŠB on Legalweb: Ivo Průša, Jana Guričová and Ján Béreš on creativity, stability and innovation in KŠB
Kocián Šolc Balaštík has been featured in a recent in-depth interview published by Legalweb, with contributions from partner Ivo Průša and counsels Jana Guričová and Ján Béreš. The interview offers insight into the firm’s core values and its direction in an evolving legal market.
